
Sanofi (SNY) Latest News & Updates
Explore latest Sanofi (SNY) News and Updates
Stay updated on Sanofi (SNY) with the latest news, market trends, and key developments to support informed investing decisions.
Start investing in Sanofi (SNY)
Order type
Buy in
Order amount
Est. shares
0 shares





Zacks Investment Research •

Zacks Investment Research •



Zacks Investment Research •

Investopedia •




GlobeNewsWire •

Press Release: Dupixent approved in China as the first-ever biologic medicine for patients with COPD
GlobeNewsWire •

Zacks Investment Research •

Zacks Investment Research •

GlobeNewsWire •

Reuters •


Zacks Investment Research •



